According to our data and the results of other authors, it can be concluded that focal and/or global brain ischemia with reperfusion interferes with the metabolism of the amyloid protein precursor and tau protein at both the gene and protein levels, and leads to amyloid accumulation and tau protein dysfunction [15, 23, 34, 36, 67–75]. The gene discussed is MAPT; the disease is brain ischemia.